Jian-Xing Ma Selected Research

Protein Isoforms (Isoforms)

1/2021

The role of peroxisome proliferator-activated receptors in healthy and diseased eyes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jian-Xing Ma Research Topics

Disease

27	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2023 - 02/2006
23	Inflammation (Inflammations) 01/2023 - 11/2005
15	Retinal Neovascularization 11/2022 - 02/2006
13	Macular Degeneration (Age-Related Maculopathy) 06/2023 - 01/2007
10	Retinal Degeneration 01/2022 - 08/2006
9	Type 2 Diabetes Mellitus (MODY) 02/2024 - 10/2008
9	Ischemia 01/2022 - 03/2005
8	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2023 - 09/2010
8	Neoplasms (Cancer) 01/2021 - 04/2006
7	Pathologic Neovascularization 12/2022 - 04/2014
7	Leukostasis 11/2022 - 11/2012
7	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 01/2005
6	Choroidal Neovascularization 12/2021 - 11/2007
6	Corneal Neovascularization 01/2018 - 11/2005
5	Hypoxia (Hypoxemia) 01/2022 - 12/2007
5	Fibrosis (Cirrhosis) 12/2021 - 02/2006
5	Burns 01/2018 - 11/2005
4	Bites and Stings (Sting) 01/2023 - 01/2022
4	Retinal Diseases 01/2020 - 01/2007
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 06/2008
3	Stargardt Disease 01/2022 - 09/2011
3	Glioblastoma (Glioblastoma Multiforme) 11/2020 - 01/2019
3	Chronic Renal Insufficiency 01/2020 - 01/2019
2	Obesity 02/2024 - 02/2013
2	Wounds and Injuries (Trauma) 12/2023 - 12/2022
2	Uveitis 01/2021 - 01/2020
2	Eye Diseases (Eye Disease) 01/2021 - 09/2014
2	Albuminuria 01/2020 - 02/2006
2	Diabetes Complications 01/2020 - 05/2019
2	Gliosis 01/2020 - 01/2016
2	Neuroinflammatory Diseases 08/2018 - 01/2016
2	Myopia 09/2016 - 01/2015
2	Hyperglycemia 01/2016 - 01/2005
2	Hepatocellular Carcinoma (Hepatoma) 01/2012 - 04/2006
1	Weight Loss (Weight Reduction) 02/2024
1	Insulin Resistance 02/2024
1	Overweight 02/2024
1	Urogenital Abnormalities 12/2023
1	Tuberous Sclerosis 1 01/2022

Drug/Important Bio-Agent (IBA)

42	Retinaldehyde (Retinal)IBA 12/2023 - 03/2005
16	Therapeutic UsesIBA 12/2023 - 11/2005
12	Fenofibrate (CiL)FDA LinkGeneric 12/2023 - 12/2013
11	Proteins (Proteins, Gene)FDA Link 11/2022 - 06/2006
10	Oxygen (Dioxygen)IBA 12/2022 - 09/2012
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2007
8	CateninsIBA 11/2020 - 11/2012
6	kallistatinIBA 02/2024 - 09/2010
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2023 - 10/2014
6	pigment epithelium-derived factorIBA 05/2014 - 01/2005
5	Peptides (Polypeptides)IBA 01/2022 - 01/2012
5	AlkaliesIBA 01/2018 - 11/2005
4	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2005
4	PPAR alphaIBA 06/2023 - 10/2017
4	InterferonsIBA 01/2023 - 01/2022
4	RetinoidsIBA 01/2022 - 01/2017
4	oxidized low density lipoproteinIBA 01/2016 - 06/2008
4	LipidsIBA 10/2014 - 09/2010
3	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023 - 01/2022
3	LipofuscinIBA 01/2022 - 01/2013
3	Streptozocin (Streptozotocin)FDA Link 01/2022 - 11/2012
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022 - 12/2012
3	VLDL LipoproteinsIBA 12/2021 - 11/2007
3	Carrier Proteins (Binding Protein)IBA 01/2021 - 12/2007
3	Kallikreins (Kallikrein)IBA 01/2021 - 12/2007
3	Retinal Pigments (Pigments, Visual)IBA 01/2020 - 01/2015
3	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2020 - 06/2014
3	erucylphosphocholineIBA 10/2019 - 01/2012
2	AntioxidantsIBA 12/2023 - 01/2014
2	Mitochondrial DNA (mtDNA)IBA 01/2023 - 11/2022
2	Ophthalmic Solutions (Eye Drops)IBA 12/2021 - 09/2010
2	Rhodopsin (Visual Purple)IBA 01/2021 - 10/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2014
2	AlbuminsIBA 10/2019 - 09/2010
2	CreatinineIBA 10/2019 - 09/2010
2	Monoclonal AntibodiesIBA 01/2018 - 11/2012
2	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2017 - 12/2012
2	Retinal DehydrogenaseIBA 09/2016 - 01/2015
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2015 - 04/2011
2	Angiogenesis InhibitorsIBA 01/2012 - 06/2006
2	plasminogen kringle 5IBA 01/2012 - 11/2005
2	LDL Lipoproteins (beta Lipoproteins)IBA 09/2008 - 06/2008
2	Transforming Growth Factor beta (TGF-beta)IBA 06/2006 - 01/2005
1	Messenger RNA (mRNA)IBA 02/2024
1	Insulin (Novolin)FDA Link 02/2024
1	MicroRNAs (MicroRNA)IBA 10/2023
1	Small Interfering RNA (siRNA)IBA 01/2023
1	IntegrinsIBA 12/2022
1	Transcription Factors (Transcription Factor)IBA 11/2022
1	A2-E (N-retinylidene-N-retinylethanolamine)IBA 01/2022
1	OpsinsIBA 01/2022
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	EmulsionsIBA 12/2021

Therapy/Procedure

6	Therapeutics 01/2022 - 10/2010
5	Intravitreal Injections 01/2022 - 10/2010
5	Lasers (Laser) 12/2021 - 09/2012
2	Topical Administration 12/2021 - 01/2018
2	Injections 01/2020 - 01/2016
1	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 02/2024
1	Oral Administration 12/2021